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A total of 66 (98.5%) of 67 enterohemorrhagic Escherichia coli (EHEC) O157:H7 strains had increased
potassium tellurite (Te) MICs (32 to 1,024 g/ml), grew on Te-containing media, and possessed Te resistance
(ter) genes, whereas 83 (96.5%) of 86 sorbitol-fermenting (SF) EHEC O157:NM strains had Te MICs of <4
g/ml, did not grow on Te-containing media, and lacked ter genes. Optimal detection of SF EHEC O157:NM
strains requires Te-independent strategies.
Tellurite (Te)-resistant (Ter) non-sorbitol-fermenting en-
terohemorrhagic Escherichia coli (EHEC) O157:H7 strains
cause diarrhea and hemolytic-uremic syndrome (HUS) world-
wide (17), but sorbitol-fermenting (SF) EHEC O157:NM
(nonmotile) strains have emerged as pathogens only in Europe
(1, 6, 8, 12) and Australia (3) so far. SF EHEC O157:NM
strains are not distinguishable from commensal E. coli strains
on sorbitol MacConkey agar (SMAC), and do not grow (11) on
cefixime-Te (CT)-SMAC (22), which is frequently used for
selective isolation of EHEC O157:H7 strains from feces, foods,
and the environment (2, 4, 5, 9, 13, 20, 21). Ter in EHEC
O157:H7 is associated with the ter (terZABCDEF) gene cluster
(19), duplicated in strain EDL933 in O islands OI 43 and OI 48
(14). One of these islands was originally identified in strain
86-24 (16) as the Ter and adherence-conferring island (16). Ter
in SF EHEC O157:NM strains has not been investigated. Be-
cause Te susceptibility (Tes) could thwart the detection of such
strains on media containing Te, we investigated Ter and the
presence of ter genes in a large collection of SF EHEC
O157:NM clinical isolates. We compared these characteristics
with those of EHEC O157:H7.
Isolation and characterization of strains. A total of 67
EHEC O157:H7 and 86 SF EHEC O157:NM strains were
isolated between 1987 and 2003 from patients with HUS (n 
118) or bloody (n  11) or watery (n  19) diarrhea and from
asymptomatic carriers (n  5). To avoid biases from strains
selected by their Ter, only EHEC O157 strains isolated on
Te-free media by methods described previously (6, 10, 11) were
included in this study, and they comprise a subset of the 572 E.
coli O157 strains recovered during this interval. The 67 EHEC
O157:H7 strains belonged to Shiga toxin (Stx) genotypes stx1 (2
strains), stx2 (28 strains), stx1  stx2 (6 strains), stx2c (8 strains),
stx1  stx2c (4 strains), and stx2  stx2c (19 strains). All 86 SF
EHEC O157:NM strains contained stx2 only. Te MICs (the
lowest Te concentrations which inhibited growth) were deter-
mined using a microdilution broth method (15). Each strain
was tested in duplicate and in two independent experiments
using 4  104 to 5  104 CFU/well and serial twofold concen-
trations (1 to 1,024 g/ml) of potassium Te (Sigma,
Taufkirchen, Germany) in 100 l of Luria-Bertani (LB) broth.
The ability of EHEC O157 to grow on solid media containing
the Te concentration routinely used for E. coli O157:H7 selec-
tive isolation was tested by inoculating 105 CFU from over-
night LB broth cultures on CT-SMAC (potassium Te 2.5, g/
ml; cefixime, 0.05 g/ml [Oxoid, Basingstoke, United
Kingdom]) and LB agar plus 2.5 g of potassium Te per ml
(LB-Te agar). The presence of ter genes was determined by
PCRs using primer pairs TerZ1 plus TerZ2 (terZ), TerA1 plus
TerA2 (terA), TerB1 plus TerB2 (terB), TerC1 plus TerC2
(terC), TerD1 plus TerD2 (terD), TerE1 plus TerE2 (terE), and
TerF1 plus TerF2 (terF) (19), with strains EDL933 and C600 as
positive and negative controls, respectively. Genomic DNA
was digested (BamHI and PstI; New England Biolabs, Frank-
furt, Germany), separated in 0.6% agarose, and probed under
stringent conditions with digoxigenin-labeled terC (19) (DIG
DNA labeling and detection kit; Roche Molecular Biochemi-
cals, Mannheim, Germany).
Ter and ter presence among EHEC O157. Of 67 EHEC
O157:H7 strains, 50 (74.6%) and 16 (23.9%) had high (256 to
1,024 g/ml) or intermediate (32 to 128 g/ml) Te MICs,
respectively (Table 1). All 66 Ter strains grew well on CT-
SMAC and LB-Te agar and contained terZ, terA, terB, terC,
terD, terE, and terF (Table 1). One EHEC O157:H7 strain
(5288/91) had a Te MIC of 1 g/ml, failed to grow on CT-
SMAC and LB-Te agar, and lacked all ter genes (Table 1). In
contrast, 83 (96.5%) of 86 SF EHEC O157:NM strains were
susceptible to Te (Te MICs of 4 g/ml) (Table 1). Of these
83 strains, 70 (84.3%) failed to grow on CT-SMAC and LB-Te
agar and 13 strains (15.7%) were strongly inhibited on both
media (10 colonies grew after overnight incubation). All 83
Tes SF EHEC O157:NM strains lacked ter genes (Table 1).
* Corresponding author. Mailing address: Institut fu¨r Hygiene, Uni-
versita¨tsklinikum Mu¨nster, Robert Koch Str. 41, 48149 Mu¨nster, Ger-
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Two of three Ter SF EHEC O157:NM isolates (3226/98 and
3323/98) had Te MICs of 128 g/ml, grew well on CT-SMAC
and LB-Te agar, and contained all ter genes; the remaining Ter
(MIC, 256 g/ml) SF EHEC O157:NM strain (4180/97) had no
ter genes (Table 1).
Southern hybridization. terC was carried on a ca. 9-kb DNA
fragment in ter SF EHEC O157:NM strains 3226/98 and
3323/98 (Fig. 1, lanes 6 and 7), on a ca. 6.3-kb DNA fragment
in strain EDL933 (lane 1), and on no DNA fragments in strains
5288/91, 4180/97, and ter-negative SF EHEC O157:NM strain
493/89 (lanes 3 to 5).
Effect of Ter on detection of EHEC strains. Our study pro-
vides for the first time a basis for the inability of SF EHEC
O157:NM to grow on CT-SMAC (11), which was until now
only speculated to be caused by their Tes (12, 16). In contrast
to EHEC O157:H7, almost all SF EHEC O157:NM strains
lack ter genes and are Tes. Low Te MICs for SF EHEC O157
strains and the comparable growth inhibition of these isolates
on CT-SMAC and LB-Te agar suggest that Te, and not ce-
fixime, is the growth-inhibiting component in CT-SMAC. The
Ter and Tes correlated with the presence and absence, respec-
tively, of ter genes in all but one of the 153 EHEC O157 strains
investigated. The single Ter, ter-negative SF EHEC O157:NM
strain (4180/97) is currently being investigated for other pres-
ently known mechanisms of Ter (18). Interestingly, Southern
hybridization suggests that the genomic positions of terC differ
in the two ter SF EHEC O157:NM isolates and EHEC
O157:H7 strain EDL933 (Fig. 1). Studies are under way to
determine if the ter genes in these SF EHEC O157:NM strains
are clustered, similar to those in EDL933 (14), and to deter-
mine the genomic location of the ter cluster as well as its copy
number. Also, further studies should clarify the reasons for the
substantially lower frequency of Tes found among central Eu-
ropean EHEC O157:H7 isolates (1.5%) than among North
American E. coli O157:H7 (20%) (19). Taken together, our
data demonstrate a significant difference between EHEC
O157:H7 and SF EHEC O157:NM in the frequency of Ter and
ter genes, demonstrate a diversity among SF EHEC O157:NM
strains as far as the presence of ter genes is concerned, and
suggest that other mechanisms of Ter exist in a minority of
such strains. However, most importantly, our data clearly in-
dicate that, because of their Tes, most SF EHEC O157:NM
strains are missed by strategies currently used for the isolation
of EHEC O157:H7 strains in many clinical laboratories. A
similar observation has been reported for a subset of other Tes
EHEC strains (5). The selectivity offered by incorporating Te
into agar media, while appropriate for isolating E. coli
O157:H7 (the most important EHEC serotype worldwide),
hinders the assessment of the geographic distribution, medical
significance, and epidemiology of SF EHEC O157:NM strains,
which in Germany are the second most common cause of HUS
(6). Detection opportunities that do not select against SF
EHEC O157:NM and, optimally, specifically target these or-
ganisms (7) are needed to answer the question about the rel-
ative significance of both EHEC O157 pathogens in human
diseases.
FIG. 1. Hybridization of BamHI-PstI-digested genomic DNA from
EHEC O157 strains and controls with the terC probe. M, molecular
weight marker (1-kb DNA ladder; Gibco-BRL). In lanes 1 to 7, the
following strains are displayed (serotype, Te-MIC in micrograms per
milliliter, and the presence of ter genes as detected by PCR are given
in parentheses): lane 1, EDL933 (O157:H7, 128, ter); lane 2, C600
(not available; 1; ter negative) (negative control); lane 3, 5288/91
(O157:H7; 1; ter negative); lane 4, 4180/97 (SF O157:NM; 256; ter
negative); lane 5, 493/89 (SF O157:NM; 1; ter negative); lane 6,
3226/98 (SF O157:NM; 128; ter); lane 7, 3323/98 (SF O157:NM; 128;
ter). Two terC copies detected in EDL933 after DNA separation by
pulsed-field gel electrophoresis (19) were not distinguishable by con-
ventional gel electrophoresis.
TABLE 1. Ter and the presence of ter genes among EHEC O157:H7 and SF EHEC O157:NM strains
Serotype Total no.of strains SF
b
No. (%) of strains with a characteristic
Te MIC (g/ml) in range of: Robust growthc on: No or stronglyreduced growthd on: ter genes
e







O157:H7 67 0 50 (74.6)f 16 (23.9)f 0 (0) 1 (1.5) 66 (98.5) 66 (98.5) 1 (1.5) 1 (1.5) 66 (98.5)g 1 (1.5)
O157:NMa 86 86 1 (1.2)f 2 (2.3)f 40 (46.5) 43 (50.0) 3 (3.5) 3 (3.5) 83 (96.5) 83 (96.5) 2h (2.3)g 84i (97.7)
a NM, nonmotile.
b SF, sorbitol fermentation as determined after overnight incubation on SMAC agar.
c Robust growth, 1,000 colonies of normal size per plate.
d No growth, no colonies grown; strongly reduced growth, 10 colonies reduced in size present after overnight incubation.
e As determined by PCRs targeting terZ, terA, terB, terC, terD, terE, and terF (19); present, all genes investigated were present; absent, all genes investigated were
absent.
f Tellurite resistance (Ter): EHEC O157:H7 versus SF EHEC O157:NM, P  0.000001 by the 2 test.
g Presence of ter genes: EHEC O157:H7 versus SF EHEC O157:NM, P  0.000001 by the 2 test.
h Two of three Ter strains; the third was negative for ter genes.
i 83 Tes strains and 1 Ter strain.
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